Studies of monkey complement: Measurement of cynomolgus monkey CH50, ACH50, C4, C2 and C3

Xenotransplantation

Volumn 15, Issue 1, 2008, Pages 14-19

  Xu, Hengjie ^a   Kitano, Etsuko ^a   Sato, Yu ^a   Kobayashi, Chizuko ^a   Firdawes, Sabere ^a   Kitamura, Hajime ^b   Fukuzawa, Masahiro ^a   Miyagawa, Shuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANSAI UNIVERSITY OF WELFARE SCIENCES   (Japan)

Author keywords

Alternative complement pathway; Complement; Cynomolgus monkey; DAF(D55); Xenotransplantation

Indexed keywords

COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; ZYMOSAN;

ANIMAL CELL; ARTICLE; CELL SURFACE; COMPLEMENT SYSTEM; CONTROLLED STUDY; FLOW CYTOMETRY; HEMOLYSIS; MONKEY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEROLOGY; WESTERN BLOTTING;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; COMPLEMENT ACTIVATION; COMPLEMENT C2; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; ERYTHROCYTES; HUMANS; MACACA FASCICULARIS; SWINE;

EID: 40549112339     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2007.00438.x     Document Type: Article

References (27)

1. Tai HC, Ezzelarab M, Hara H, Ayares D, Cooper DK. Progress in xenotransplantation following the introduction of gene-knockout technology. Transpl Int 2007 20 : 107 117.
2. Miyagawa S, Murakami H, Takahagi Y et al. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J Biol Chem 2001 276 : 39310 39319.
3. Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 1982 129 : 184 189.
4. White DJ, Yannoutsos N. Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man. Res Immunol 1996 147 : 88 94.
5. Murakami H, Nagashima H, Takahagi Y et al. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter. Mol Reprod Dev 2002 61 : 302 311.
6. Miyagawa S, Hirose H, Shirakura R et al. The mechanism of discordant xenograft rejection. Transplantation 1988 46 : 825 830.
7. Miyagawa S, Shirakura R, Iwata K et al. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAF hybrid, on complement-mediated swine endothelial cell lysis. Transplantation 1994 58 : 834 840.
8. Galili U. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Transfus Apher Sci 2006 35 : 45 58.
9. Takahagi Y, Fujimura T, Miyagawa S et al. Production of α1,3-galactosyltransferase gene knockout pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III. Mol Reprod Dev 2005 71 : 331 338.
10. Komoda H, Miyagawa S, Omori T et al. Adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) indicate a prolonged survival in the cynomolgus monkey. Xenotransplantation 2005 12 : 209 216.
11. Hering BJ, Wijkstrom M, Graham ML et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006 12 : 301 303.
12. Teranishi K, Manez R, Awwad M et al. Anti-Gal alpha 1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates. Xenotransplantation 2002 9 : 148 154.
13. Ellingsworth LR, Holmberg CA, Osburn BI. Hemolytic complement measurement in eleven species of nonhuman primates. Vet Immunol Immunopathol 1983 5 : 141 149.
14. Saadi S, Takahashi T, Holzknecht RA, Platt JL. Pathways to acute humoral rejection. Am J Pathol 2004 164 : 1073 1080.
15. Ehrnfelt C, Kumagai-Braesch M, Uzunel M, Holgersson J. Adult porcine islets produce MCP-1 and recruit human monocytes in vitro. Xenotransplantation 2004 11 : 184 194.
16. Mayer MM. Complement and complement fixation. In : Experimental Immunochemistry. Springfield, IL : Charles C Thomas, 1961 : 133 240.
17. Platts-Mills TAK, Ishizaka K. Activaton of the alternate pathway of human complement by rabbit cells. J Immunol 1974 113 : 348 358.
18. Borsos T, Rapp HJ. Chromatographic separation of the first component of complement and its assay on a molecular basis. J Immunol 1963 91 : 851 858.
19. Borsos T, Rapp HJ, Mayer MM. Studies on the second component of complement: 1. The reaction between EAC14 and C2: evidence on the single site mechanism of immune hemolysis and determination of C2 on a molecular basis. J Immunol 1961 87 : 310 325.
20. Nagaki K, Iida K, Inai S. A new method for the preparation of EAC14 cell with human or guinea-pig serum. J Immunol Methods 1974 5 : 307 317.
21. Iida K, Fujita T, Inai S, Sasaki M, Kato T. Complement fixing abilities of IgA myeloma proteins and their fragments: the activation of complement through the classical pathway. Immunochemistry 1976 13 : 747 752.
22. Kitamura H, Nishimukai H, Sano Y, Nagaki K. Study on C3-like factor in the serum of a C3-deficient subject. Immunology 1984 51 : 239 245.
23. Kitamura H, Nagano A, Kitano E. Hemolysis of normal human erythrocytes by autologous serum complement. Int Arch Allergy Immunol 1993 100 : 209 214.
24. Komoda H, Miyagawa S, Kubo T et al. A study of the xenoantigenicity of adult pig islets cells. Xenotransplantation 2004 11 : 237 246.
25. Omori T, Nishida T, Komoda H et al. A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression. Xenotransplantation 2006 13 : 455 464.
26. Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2002 2 : 346 353.
27. Miyagawa S, Kubo T, Matsunami K et al. The feature of decay accelerating factor (DAF: CD55) on natural killer cell-mediated cytotoxicity. J Immunol 2004 173 : 3945 3952.